Pharmaceutical Preparation Manufacturing federal obligations in Texas

What NAICS 325412 and Texas share on one row

NAICS 325412 and place-of-performance state TX meet here. $25,339,779,044 is the obligation sum on awards that carry both tags. It is not every federal award in Texas, not the nationwide Pharmaceutical Preparation Manufacturing total, and not cash already paid. Statewide drug-plant and depot folklore may send a reader here. Those stories are not a factory list and not an FDA census.

7,537 award actions sit behind that dollar figure — thousands of award actions behind a very large obligation total. Modifications add rows. Unique manufacturers are not published here. The join does not rank Texas against other states and does not name products inside the extract.

Open Texas federal spending for the filtered table, NAICS 325412 for the next hub, Texas industries for the remaining hub, and All spending ties for other pairs.

Thousands of pharma-manufacturing actions under a Texas filter

Dividing $25,339,779,044 by 7,537 yields about $3,362,051 per award on average. That average hides contracts, grants, and other instruments. It is not a typical drug-supply contract. A second 325412 slice on another state uses the same NAICS code and a different dollar total. Do not treat Texas’s 325412 total as a synonym for every federal drug purchase.

Statewide drug-plant and depot folklore is a coding conversation, not a packet field. Recipient rows live on the industry and state hubs, not in this narrative’s extra columns.

NAICS 325412 without a Texas overlay is a different total

The NAICS 325412 page aggregates NAICS 325412 without requiring TX geography. The Texas federal spending page aggregates all agencies and industries with Texas place of performance. Texas industries lists other industry cells in the same state. Only this tie applies both the 325412 filter and the TX filter, which is why it cites 7,537 awards and $25,339,779,044.

Place of performance in Texas is a USAspending geography field. Awards can list TX while manufacturing occurs elsewhere. 325412 awards coded to other states do not sit in this total even if a distributor’s mailroom is in Houston. This packet does not split Houston from Dallas or San Antonio.

Obligations, not outlays

An obligation is a legal commitment. An outlay is a payment. $25,339,779,044 is the former. This packet has no outlay total, no fiscal-year split, and no de-obligation history. Citing the figure as money already spent in Texas over-reads the field.

Award count 7,537 is a record count, not a payment count. Readers who need transaction-level detail should use Texas federal spending, NAICS 325412, and Texas industries. All spending ties does not hide a blended statewide total under this slug.

What this pair does not prove

A large 325412 total in Texas does not mean manufacturers caused Texas’s health mix, and it does not connect these obligations to campaign contributions. Correlation between plant geography and federal awards is expected; it is not a finding about drug prices or waste.

Keep $25,339,779,044 labeled as NAICS 325412 obligations with Texas place of performance. FEC individual contributions are a different dataset. An industry name that appears near a donor occupation is a coincidence of labeling, not a cash pipeline into USAspending.

How to cite the Texas–325412 pair

A clean footnote names NAICS 325412 (Pharmaceutical Preparation Manufacturing), Texas place of performance, $25,339,779,044 in obligations, and 7,537 awards on USAspending.gov. Keep the obligation word. Do not call $25,339,779,044 cash outlays. Mean dollars per action remain about $3,362,051 if you divide those two facts — a ratio, not a typical drug-supply contract.

Texas federal spending, NAICS 325412, Texas industries, and All spending ties keep the same unit. A later ingest can restate $25,339,779,044 without changing the join definition. Rewrite only the sentence whose source moved. Houston-versus-Dallas folklore is not a metro split in this packet. Product names are not packet fields. Keep the obligation label in every reuse. Correlation is not causation.

Questions

How much has NAICS 325412 obligated in Texas?

USAspending.gov records $25,339,779,044 in obligations for NAICS 325412 with Texas place of performance, covering 7,537 awards. That is an obligation total, not an outlay total, and not the nationwide Pharma manufacturing total. Original filings remain on the source sites.

Does this total include every Texas drug plant?

The extract lists 7,537 award actions totaling $25,339,779,044. Average obligation per award is about $3,362,051, a ratio of two packet facts, not a typical drug-supply contract. Unique recipients are not published here, and the row count is not a company census. Original filings remain on the source sites.

Is this a Houston-only pharma total?

No. $25,339,779,044 and 7,537 awards are statewide Texas place of performance. This packet does not split Houston from Dallas or San Antonio. A regional cut would be a different extract, not this NAICS–state join. Original filings remain on the source sites.

Where are the live Texas and NAICS 325412 tables?

Texas federal spending shows statewide spending. NAICS 325412 shows NAICS 325412 without a state filter. Texas industries lists other Texas industry cells. All spending ties lists other pairs. This page is the join of those two filters, not a restatement of either hub. Original filings remain on the source sites.